Insider Trades91 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 21, 2026 | Sell | RNA | Teresa Mccarthy | Chief Human Resources Officer | 2,929 | $72.45 | $207.8M | -83.37% | +6.55% | $212.2K | -1.26% | — | Stalk |
| Jan 21, 2026 | Sell | RNA | Michael F Maclean | Chief Financial Officer | 4,542 | $72.45 | $207.8M | -83.37% | +6.55% | $329.1K | -3.61% | — | Stalk |
| Jan 21, 2026 | Sell | RNA | Steven George Hughes | Chief Medical Officer | 4,895 | $72.45 | $207.8M | -83.37% | +6.55% | $354.6K | -6.90% | — | Stalk |
| Jan 21, 2026 | Sell | RNA | W. Michael Flanagan | Chief Scientific Officer | 6,534 | $72.45 | $207.8M | -83.37% | +6.55% | $473.4K | -3.64% | — | Stalk |
| Jan 21, 2026 | Sell | RNA | Sarah Boyce | President and CEO | 14,387 | $72.45 | $207.8M | -83.37% | +6.55% | $1.0M | -2.57% | — | Stalk |
| Jan 7, 2026 | Sell | RNA | Teresa Mccarthy | Chief Human Resources Officer | 1,965 | $72.23 | $207.8M | -83.37% | +6.55% | $141.9K | -1.65% | — | Stalk |
| Jan 7, 2026 | Sell | RNA | Michael F Maclean | Chief Financial Officer | 1,974 | $72.23 | $207.8M | -83.37% | +6.55% | $142.6K | -3.00% | — | Stalk |
| Jan 7, 2026 | Sell | RNA | W. Michael Flanagan | Chief Scientific Officer | 2,373 | $72.23 | $207.8M | -83.37% | +6.55% | $171.4K | -2.52% | — | Stalk |
| Jan 7, 2026 | Sell | RNA | Steven George Hughes | Chief Medical Officer | 2,373 | $72.23 | $207.8M | -83.37% | +6.55% | $171.4K | -6.11% | — | Stalk |
| Jan 7, 2026 | Sell | RNA | John B Moriarty | Chief Legal Officer | 2,374 | $72.23 | $207.8M | -83.37% | +6.55% | $171.5K | -3.09% | — | Stalk |
| Jan 7, 2026 | Sell | RNA | Charles Iii Calderaro | Chief Technical Officer | 3,727 | $72.23 | $207.8M | -83.37% | +6.55% | $269.2K | -6.96% | — | Stalk |
| Jan 7, 2026 | Sell | RNA | Sarah Boyce | President and CEO | 8,576 | $72.23 | $207.8M | -83.37% | +6.55% | $619.4K | -2.94% | — | Stalk |
| Dec 17, 2025 | Sell | RNA | Charles Iii Calderaro | Chief Technical Officer | 9,726 | $71.87 | $207.8M | -83.37% | +6.55% | $699.0K | -15.38% | — | Stalk |
| Dec 17, 2025 | Sell | RNA | W. Michael Flanagan | Chief Scientific Officer | 13,695 | $71.87 | $207.8M | -83.37% | +6.55% | $984.3K | -12.72% | — | Stalk |
| Dec 17, 2025 | Sell | RNA | Sarah Boyce | President and CEO | 44,901 | $25.20 | $207.8M | -83.37% | +6.55% | $1.1M | -6.82% | — | Stalk |
| Dec 17, 2025 | Sell | RNA | Teresa Mccarthy | Chief Human Resources Officer | 17,298 | $71.87 | $207.8M | -83.37% | +6.55% | $1.2M | -12.71% | — | Stalk |
| Dec 17, 2025 | Sell | RNA | John B Moriarty | Chief Legal Officer | 26,824 | $71.87 | $207.8M | -83.37% | +6.55% | $1.9M | -25.85% | — | Stalk |
| Dec 17, 2025 | Sell | RNA | Kathleen P. Gallagher | Chief Program Officer | 41,366 | $71.87 | $207.8M | -83.37% | +6.55% | $3.0M | -19.60% | — | Stalk |
| Dec 17, 2025 | Sell | RNA | Eric Mosbrooker | Chief Commercial Officer | 47,990 | $71.87 | $207.8M | -83.37% | +6.55% | $3.4M | -22.07% | — | Stalk |
| Oct 22, 2025 | Sell | RNA | Steven George Hughes | Chief Medical Officer | 4,418 | $28.85 | $207.8M | -83.37% | +6.55% | $127.5K | +0.00% | 10b5-1 | Stalk |
| Oct 15, 2025 | Sell | RNA | Teresa Mccarthy | Chief Human Resources Officer | 40,000 | $36.25 | $207.8M | -83.37% | +6.55% | $1.4M | +0.00% | 10b5-1 | Stalk |
| Oct 3, 2025 | Sell | RNA | Eric Mosbrooker | Chief Commercial Officer | 13,124 | $27.21 | $207.8M | -83.37% | +6.55% | $357.2K | +0.00% | 10b5-1 | Stalk |
| Sep 22, 2025 | Sell | RNA | Steven George Hughes | Chief Medical Officer | 4,416 | $25.37 | $207.8M | -83.37% | +6.55% | $112.0K | +0.00% | 10b5-1 | Stalk |
| Sep 15, 2025 | Sell | RNA | Steven George Hughes | Chief Medical Officer | 3,084 | $25.99 | $207.8M | -83.37% | +6.55% | $80.2K | +0.00% | 10b5-1 | Stalk |
| Sep 15, 2025 | Sell | RNA | Teresa Mccarthy | Chief Human Resources Officer | 30,000 | $31.87 | $207.8M | -83.37% | +6.55% | $956.2K | +0.00% | 10b5-1 | Stalk |
| Sep 11, 2025 | Sell | RNA | W. Michael Flanagan | Chief Scientific Officer | 40,000 | $26.58 | $207.8M | -83.37% | +6.55% | $1.1M | +0.00% | 10b5-1 | Stalk |
| Sep 5, 2025 | Sell | RNA | Sarah Boyce | President and CEO | 100,000 | $25.59 | $207.8M | -83.37% | +6.55% | $2.6M | +0.00% | 10b5-1 | Stalk |
| Sep 3, 2025 | Sell | RNA | Eric Mosbrooker | Chief Commercial Officer | 13,126 | $28.06 | $207.8M | -83.37% | +6.55% | $368.3K | +0.00% | 10b5-1 | Stalk |
| Sep 2, 2025 | Sell | RNA | Kathleen P. Gallagher | Chief Program Officer | 188 | $47.42 | $207.8M | -83.37% | +6.55% | $8.9K | -0.37% | 10b5-1 | Stalk |
| Aug 28, 2025 | Sell | RNA | Sarah Boyce | President and CEO | 50,000 | $25.31 | $207.8M | -83.37% | +6.55% | $1.3M | +0.00% | 10b5-1 | Stalk |
| Aug 22, 2025 | Sell | RNA | Steven George Hughes | Chief Medical Officer | 4,416 | $28.28 | $207.8M | -83.37% | +6.55% | $124.9K | +0.00% | 10b5-1 | Stalk |
| Aug 15, 2025 | Sell | RNA | Teresa Mccarthy | Chief Human Resources Officer | 20,000 | $34.45 | $207.8M | -83.37% | +6.55% | $689.0K | +0.00% | 10b5-1 | Stalk |
| Aug 13, 2025 | Sell | RNA | Steven George Hughes | Chief Medical Officer | 3,084 | $26.62 | $207.8M | -83.37% | +6.55% | $82.1K | +0.00% | 10b5-1 | Stalk |
| Aug 6, 2025 | Sell | RNA | Michael F Maclean | Chief Financial Officer | 30,914 | $42.73 | $207.8M | -83.37% | +6.55% | $1.3M | -31.96% | 10b5-1 | Stalk |
| Aug 6, 2025 | Sell | RNA | Steven George Hughes | Chief Medical Officer | 128,885 | $31.50 | $207.8M | -83.37% | +6.55% | $4.1M | -3.47% | 10b5-1 | Stalk |
| Aug 6, 2025 | Sell | RNA | Eric Mosbrooker | Chief Commercial Officer | 255,494 | $26.98 | $207.8M | -83.37% | +6.55% | $6.9M | -1.23% | 10b5-1 | Stalk |
| Aug 4, 2025 | Sell | RNA | John B Moriarty | Chief Legal Officer | 2,245 | $36.21 | $207.8M | -83.37% | +6.55% | $81.3K | -4.49% | — | Stalk |
| Jun 17, 2025 | Sell | RNA | Kathleen P. Gallagher | Chief Program Officer | 911 | $30.24 | $207.8M | -83.37% | +6.55% | $27.5K | -1.78% | 10b5-1 | Stalk |
| Jun 11, 2025 | Sell | RNA | W. Michael Flanagan | Chief Scientific Officer | 40,000 | $23.55 | $207.8M | -83.37% | +6.55% | $942.1K | +0.00% | 10b5-1 | Stalk |
| Jun 2, 2025 | Sell | RNA | Kathleen P. Gallagher | Chief Program Officer | 11,750 | $24.57 | $207.8M | -83.37% | +6.55% | $288.7K | +0.00% | 10b5-1 | Stalk |
| May 1, 2025 | Sell | RNA | Kathleen P. Gallagher | Chief Program Officer | 11,750 | $24.52 | $207.8M | -83.37% | +6.55% | $288.1K | +0.00% | 10b5-1 | Stalk |
| Apr 1, 2025 | Sell | RNA | Kathleen P. Gallagher | Chief Program Officer | 11,750 | $21.32 | $207.8M | -83.37% | +6.55% | $250.5K | +0.00% | 10b5-1 | Stalk |
| Mar 20, 2025 | Sell | RNA | Teresa Mccarthy | Chief Human Resources Officer | 7,778 | $31.06 | $207.8M | -83.37% | +6.55% | $241.6K | -7.41% | — | Stalk |
| Mar 20, 2025 | Sell | RNA | Michael F Maclean | Chief Financial Officer | 7,935 | $31.06 | $207.8M | -83.37% | +6.55% | $246.4K | -7.58% | — | Stalk |
| Mar 20, 2025 | Sell | RNA | Steven George Hughes | Chief Medical Officer | 9,578 | $31.06 | $207.8M | -83.37% | +6.55% | $297.5K | -11.62% | — | Stalk |
| Mar 20, 2025 | Sell | RNA | W. Michael Flanagan | Chief Scientific Officer | 11,780 | $31.06 | $207.8M | -83.37% | +6.55% | $365.9K | -12.81% | — | Stalk |
| Mar 20, 2025 | Sell | RNA | Sarah Boyce | President and CEO | 31,540 | $31.06 | $207.8M | -83.37% | +6.55% | $979.6K | -9.35% | — | Stalk |
| Mar 11, 2025 | Sell | RNA | W. Michael Flanagan | Chief Scientific Officer | 40,000 | $22.18 | $207.8M | -83.37% | +6.55% | $887.0K | +0.00% | 10b5-1 | Stalk |
| Mar 3, 2025 | Sell | RNA | Kathleen P. Gallagher | Chief Program Officer | 11,750 | $22.06 | $207.8M | -83.37% | +6.55% | $259.2K | +0.00% | 10b5-1 | Stalk |
| Feb 3, 2025 | Sell | RNA | Kathleen P. Gallagher | Chief Program Officer | 11,750 | $24.40 | $207.8M | -83.37% | +6.55% | $286.7K | +0.00% | 10b5-1 | Stalk |
| Jan 21, 2025 | Sell | RNA | Teresa Mccarthy | Chief Human Resources Officer | 2,959 | $28.59 | $207.8M | -83.37% | +6.55% | $84.6K | -1.38% | — | Stalk |
| Jan 21, 2025 | Sell | RNA | Michael F Maclean | Chief Financial Officer | 3,287 | $28.59 | $207.8M | -83.37% | +6.55% | $94.0K | -1.53% | — | Stalk |
| Jan 21, 2025 | Sell | RNA | Steven George Hughes | Chief Medical Officer | 3,947 | $28.59 | $207.8M | -83.37% | +6.55% | $112.9K | -2.31% | — | Stalk |
| Jan 21, 2025 | Sell | RNA | W. Michael Flanagan | Chief Scientific Officer | 5,672 | $28.60 | $207.8M | -83.37% | +6.55% | $162.2K | -2.96% | — | Stalk |
| Jan 21, 2025 | Sell | RNA | Kathleen P. Gallagher | Chief Program Officer | 9,411 | $29.53 | $207.8M | -83.37% | +6.55% | $277.9K | -4.04% | 10b5-1 | Stalk |
| Jan 21, 2025 | Sell | RNA | Sarah Boyce | President and CEO | 10,397 | $28.59 | $207.8M | -83.37% | +6.55% | $297.3K | -1.50% | — | Stalk |
| Dec 18, 2024 | Sell | RNA | Teresa Mccarthy | Chief Human Resources Officer | 11,151 | $32.66 | $207.8M | -83.37% | +6.55% | $364.2K | -11.86% | — | Stalk |
| Dec 18, 2024 | Sell | RNA | Michael F Maclean | Chief Financial Officer | 11,151 | $32.66 | $207.8M | -83.37% | +6.55% | $364.2K | -11.85% | — | Stalk |
| Dec 18, 2024 | Sell | RNA | W. Michael Flanagan | CSTO | 12,742 | $32.66 | $207.8M | -83.37% | +6.55% | $416.2K | -14.92% | — | Stalk |
| Dec 18, 2024 | Sell | RNA | Sarah Boyce | President and CEO | 31,855 | $32.66 | $207.8M | -83.37% | +6.55% | $1.0M | -10.72% | — | Stalk |
| Dec 16, 2024 | Sell | RNA | Teresa Mccarthy | Chief Human Resources Officer | 50,000 | $23.74 | $207.8M | -83.37% | +6.55% | $1.2M | +0.00% | 10b5-1 | Stalk |
| Dec 11, 2024 | Sell | RNA | W. Michael Flanagan | CSTO | 48,000 | $29.12 | $207.8M | -83.37% | +6.55% | $1.4M | +0.00% | 10b5-1 | Stalk |
| Nov 18, 2024 | Sell | RNA | Teresa Mccarthy | Chief Human Resources Officer | 50,000 | $27.68 | $207.8M | -83.37% | +6.55% | $1.4M | +0.00% | 10b5-1 | Stalk |
| Nov 6, 2024 | Sell | RNA | Michael F Maclean | Chief Financial Officer | 185,376 | $29.72 | $207.8M | -83.37% | +6.55% | $5.5M | -4.28% | 10b5-1 | Stalk |
| Oct 16, 2024 | Sell | RNA | Teresa Mccarthy | Chief Human Resources Officer | 50,000 | $31.37 | $207.8M | -83.37% | +6.55% | $1.6M | +0.00% | 10b5-1 | Stalk |
| Oct 1, 2024 | Sell | RNA | W. Michael Flanagan | CSTO | 125,000 | $37.18 | $207.8M | -83.37% | +6.55% | $4.6M | +0.00% | 10b5-1 | Stalk |
| Sep 23, 2024 | Sell | RNA | Michael F Maclean | Chief Financial Officer | 11,510 | $44.00 | $207.8M | -83.37% | +6.55% | $506.4K | -10.67% | — | Stalk |
| Sep 23, 2024 | Sell | RNA | Teresa Mccarthy | Chief Human Resources Officer | 13,153 | $44.00 | $207.8M | -83.37% | +6.55% | $578.7K | -16.01% | — | Stalk |
| Sep 23, 2024 | Sell | RNA | W. Michael Flanagan | CSTO | 25,000 | $43.95 | $207.8M | -83.37% | +6.55% | $1.1M | -13.65% | — | Stalk |
| Sep 23, 2024 | Sell | RNA | Sarah Boyce | President and CEO | 32,880 | $44.00 | $207.8M | -83.37% | +6.55% | $1.4M | -12.29% | — | Stalk |
| Sep 11, 2024 | Sell | RNA | Teresa Mccarthy | Chief Human Resources Officer | 50,000 | $27.31 | $207.8M | -83.37% | +6.55% | $1.4M | +0.00% | 10b5-1 | Stalk |
| Sep 11, 2024 | Sell | RNA | W. Michael Flanagan | CSTO | 207,894 | $33.36 | $207.8M | -83.37% | +6.55% | $6.9M | -2.21% | 10b5-1 | Stalk |
| Aug 6, 2024 | Sell | RNA | Sarah Boyce | President and CEO | 56,000 | $22.30 | $207.8M | -83.37% | +6.55% | $1.2M | +0.00% | 10b5-1 | Stalk |
| Jul 9, 2024 | Sell | RNA | Sarah Boyce | President and CEO | 56,000 | $20.59 | $207.8M | -83.37% | +6.55% | $1.2M | +0.00% | 10b5-1 | Stalk |
| Jun 18, 2024 | Sell | RNA | Teresa Mccarthy | Chief Human Resources Officer | 9,864 | $39.13 | $207.8M | -83.37% | +6.55% | $386.0K | -23.47% | — | Stalk |
| Jun 18, 2024 | Sell | RNA | W. Michael Flanagan | CSTO | 10,106 | $39.13 | $207.8M | -83.37% | +6.55% | $395.4K | -16.60% | — | Stalk |
| Jun 18, 2024 | Sell | RNA | Michael F Maclean | Chief Financial Officer | 11,228 | $39.13 | $207.8M | -83.37% | +6.55% | $439.3K | -16.25% | — | Stalk |
| Jun 18, 2024 | Sell | RNA | Sarah Boyce | President and CEO | 32,074 | $39.13 | $207.8M | -83.37% | +6.55% | $1.3M | -18.37% | — | Stalk |
| Jun 12, 2024 | Sell | RNA | Michael F Maclean | Chief Financial Officer | 208,490 | $22.27 | $207.8M | -83.37% | +6.55% | $4.6M | +0.00% | 10b5-1 | Stalk |
| Jun 12, 2024 | Sell | RNA | Sarah Boyce | President and CEO | 600,000 | $19.93 | $207.8M | -83.37% | +6.55% | $12.0M | +0.00% | 10b5-1 | Stalk |
| Jun 4, 2024 | Sell | RNA | Sarah Boyce | President and CEO | 56,000 | $14.33 | $207.8M | -83.37% | +6.55% | $802.5K | +0.00% | 10b5-1 | Stalk |
| May 14, 2024 | Sell | RNA | Michael F Maclean | Chief Financial Officer | 150,000 | $18.55 | $207.8M | -83.37% | +6.55% | $2.8M | +0.00% | 10b5-1 | Stalk |
| May 7, 2024 | Sell | RNA | Sarah Boyce | President and CEO | 56,000 | $13.39 | $207.8M | -83.37% | +6.55% | $749.8K | +0.00% | 10b5-1 | Stalk |
| Apr 2, 2024 | Sell | RNA | Sarah Boyce | President and CEO | 56,000 | $13.74 | $207.8M | -83.37% | +6.55% | $769.6K | +0.00% | — | Stalk |
| Mar 13, 2024 | Sell | RNA | Michael F Maclean | Chief Financial Officer | 80,000 | $16.67 | $207.8M | -83.37% | +6.55% | $1.3M | +0.00% | — | Stalk |
| Mar 8, 2024 | Sell | RNA | Sarah Boyce | President and CEO | 224,000 | $11.47 | $207.8M | -83.37% | +6.55% | $2.6M | +0.00% | — | Stalk |
| Mar 1, 2024 | Sell | RNA | Sarah Boyce | President and CEO | 168,000 | $10.69 | $207.8M | -83.37% | +6.55% | $1.8M | +0.00% | — | Stalk |
| Jan 22, 2024 | Sell | RNA | Michael F Maclean | Chief Financial Officer | 1,616 | $10.13 | $207.8M | -83.37% | +6.55% | $16.4K | -1.30% | — | Stalk |
| Jan 22, 2024 | Sell | RNA | Teresa Mccarthy | Chief Human Resources Officer | 2,065 | $10.13 | $207.8M | -83.37% | +6.55% | $20.9K | -2.13% | — | Stalk |
| Jan 22, 2024 | Sell | RNA | W. Michael Flanagan | CSTO | 4,129 | $10.13 | $207.8M | -83.37% | +6.55% | $41.8K | -3.23% | — | Stalk |
| Jan 22, 2024 | Sell | RNA | Sarah Boyce | President and CEO | 5,092 | $10.13 | $207.8M | -83.37% | +6.55% | $51.6K | -1.46% | — | Stalk |